Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 2
1949 1
1951 2
1952 1
1953 1
1954 2
1955 1
1956 1
1957 1
1958 1
1959 3
1960 2
1961 1
1963 3
1964 3
1965 2
1966 2
1967 8
1968 7
1969 2
1970 2
1971 6
1972 4
1973 4
1974 7
1975 2
1976 3
1977 10
1978 3
1979 4
1980 4
1982 4
1983 10
1984 5
1985 28
1986 2
1987 2
1988 6
1989 3
1990 4
1991 4
1992 5
1993 23
1994 3
1995 5
1996 7
1997 7
1998 6
1999 7
2000 15
2001 6
2002 7
2003 16
2004 20
2005 18
2006 18
2007 1
2008 5
2009 13
2010 8
2011 10
2012 13
2013 17
2014 21
2015 29
2016 23
2017 22
2018 15
2019 15
2020 21
2021 28
2022 25
2023 24
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

609 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean obesity and intern (2,863 results)?
Atrial Fibrillation.
Al-Khatib SM. Al-Khatib SM. Ann Intern Med. 2023 Jul;176(7):ITC97-ITC112. doi: 10.7326/AITC202307180. Epub 2023 Jul 11. Ann Intern Med. 2023. PMID: 37429028 Review.
Managing risk factors for AF, such as hypertension, diabetes, and obesity, remains paramount in prevention of this condition....
Managing risk factors for AF, such as hypertension, diabetes, and obesity, remains paramount in prevention of this condition....
Binge-Eating Disorder in Adults: A Systematic Review and Meta-analysis.
Brownley KA, Berkman ND, Peat CM, Lohr KN, Cullen KE, Bann CM, Bulik CM. Brownley KA, et al. Ann Intern Med. 2016 Sep 20;165(6):409-20. doi: 10.7326/M15-2455. Epub 2016 Jun 28. Ann Intern Med. 2016. PMID: 27367316 Free PMC article. Review.
Topiramate reduced weight and increased sympathetic nervous system arousal, and lisdexamfetamine reduced weight and appetite. LIMITATIONS: Most study participants were overweight or obese white women aged 20 to 40 years. Many treatments were examined only in single studies …
Topiramate reduced weight and increased sympathetic nervous system arousal, and lisdexamfetamine reduced weight and appetite. LIMITATIONS: M …
Obesity.
Tsai AG, Bessesen DH. Tsai AG, et al. Ann Intern Med. 2019 Mar 5;170(5):ITC33-ITC48. doi: 10.7326/AITC201903050. Ann Intern Med. 2019. PMID: 30831593 Review.
The role of internists in evaluating obesity is to assess the burden of weight-related disease, mitigate secondary causes of weight gain (medications, sleep deprivation), and solicit patient motivation for weight loss. ...All patients wishing to lose weight should be encou …
The role of internists in evaluating obesity is to assess the burden of weight-related disease, mitigate secondary causes of weight g …
Obesity.
Gilden AH, Catenacci VA, Taormina JM. Gilden AH, et al. Ann Intern Med. 2024 May;177(5):ITC65-ITC80. doi: 10.7326/AITC202405210. Epub 2024 May 14. Ann Intern Med. 2024. PMID: 38739920 Review.
Obesity is a common condition and a major cause of morbidity and mortality. Fortunately, weight loss treatment can reduce obesity-related complications. This review summarizes the evidence-based strategies physicians can employ to identify, prevent, and treat obe …
Obesity is a common condition and a major cause of morbidity and mortality. Fortunately, weight loss treatment can reduce obesity …
Insufficient sleep undermines dietary efforts to reduce adiposity.
Nedeltcheva AV, Kilkus JM, Imperial J, Schoeller DA, Penev PD. Nedeltcheva AV, et al. Ann Intern Med. 2010 Oct 5;153(7):435-41. doi: 10.7326/0003-4819-153-7-201010050-00006. Ann Intern Med. 2010. PMID: 20921542 Free PMC article. Clinical Trial.
Effectiveness of Motivational Interviewing in Managing Overweight and Obesity : A Systematic Review and Meta-analysis.
Michalopoulou M, Ferrey AE, Harmer G, Goddard L, Kebbe M, Theodoulou A, Jebb SA, Aveyard P. Michalopoulou M, et al. Ann Intern Med. 2022 Jun;175(6):838-850. doi: 10.7326/M21-3128. Epub 2022 Mar 29. Ann Intern Med. 2022. PMID: 35344379 Review.
BACKGROUND: Motivational interviewing (MI) is potentially useful in management of overweight and obesity, but staff training and increased delivery time are barriers, and its effectiveness independent of other behavioral components is unclear. ...DATA SYNTHESIS: Forty-six …
BACKGROUND: Motivational interviewing (MI) is potentially useful in management of overweight and obesity, but staff training and incr …
Obesity in adulthood and its consequences for life expectancy: a life-table analysis.
Peeters A, Barendregt JJ, Willekens F, Mackenbach JP, Al Mamun A, Bonneux L; NEDCOM, the Netherlands Epidemiology and Demography Compression of Morbidity Research Group. Peeters A, et al. Ann Intern Med. 2003 Jan 7;138(1):24-32. doi: 10.7326/0003-4819-138-1-200301070-00008. Ann Intern Med. 2003. PMID: 12513041 Free article.
Forty-year-old female nonsmokers lost 7.1 years and 40-year-old male nonsmokers lost 5.8 years because of obesity. Obese female smokers lost 7.2 years and obese male smokers lost 6.7 years of life expectancy compared with normal-weight smokers. Obese f …
Forty-year-old female nonsmokers lost 7.1 years and 40-year-old male nonsmokers lost 5.8 years because of obesity. Obese femal …
Time-Restricted Eating Without Calorie Counting for Weight Loss in a Racially Diverse Population : A Randomized Controlled Trial.
Lin S, Cienfuegos S, Ezpeleta M, Gabel K, Pavlou V, Mulas A, Chakos K, McStay M, Wu J, Tussing-Humphreys L, Alexandria SJ, Sanchez J, Unterman T, Varady KA. Lin S, et al. Ann Intern Med. 2023 Jul;176(7):885-895. doi: 10.7326/M23-0052. Epub 2023 Jun 27. Ann Intern Med. 2023. PMID: 37364268 Clinical Trial.
SETTING: University of Illinois Chicago from January 2021 to September 2022. PARTICIPANTS: 90 adults with obesity. INTERVENTION: 8-hour TRE (eating between noon and 8:00 p.m. only, without calorie counting), CR (25% energy restriction daily), or control (eating over a peri …
SETTING: University of Illinois Chicago from January 2021 to September 2022. PARTICIPANTS: 90 adults with obesity. INTERVENTION: 8-ho …
In overweight or obesity without diabetes, weekly semaglutide vs. daily liraglutide increased weight loss at 68 wk.
Kauffman RP. Kauffman RP. Ann Intern Med. 2022 May;175(5):JC56. doi: 10.7326/J22-0023. Epub 2022 May 3. Ann Intern Med. 2022. PMID: 35500264 Clinical Trial.
Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: the STEP 8 randomized clinical trial. JAMA. 2022;327:138-50. 35015037....
Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: …
609 results